Niznik Receives Pilot Funding for Deprescribing Research
Joshua Niznik, PharmD, PhD, was awarded pilot funding from the US Deprescribing Research Network to study deprescribing bisphosphonates in nursing home residents with dementia. This pilot project will lay the foundation for further explorations of caregiver and provider perspectives and the implications of deprescribing for clinical outcomes and cost-effectiveness in older nursing home residents with dementia.